Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies
- PMID: 8205554
Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies
Abstract
The precise localization of carcinoembryonic antigen (CEA) and non-specific cross-reacting 50-kDa antigen (NCA 50) in normal colon mucosa and colon adenocarcinoma was investigated by using an indirect immunoperoxidase electron microscopic technique with specific monoclonal antibodies. In normal adult colon both antigens were localized to microvesicles and filaments of the "fuzzy coat" on the apical surface of the epithelial cells. In addition, NCA 50 was found in the narrow spaces between adjoining microvilli. Mature columnar cells at the free luminal surface contained most of the antigen positive material. CEA and NCA 50 were also detected as intracellular components of goblet cells. In multilayered tumor glands, the cell surface expression of the antigens was dependent on the position of the tumor cell in the gland. The neoplastic cells showed either a predominant apical labeling or a positive staining of almost the entire cell surface. Some of the neoplastic cells contained CEA in so-called "intracellular lumina." In contrast to normal colon epithelial cells most tumor cells synthesized NCA 50 actively. In normal colonic mucosa, unlike in cancerous tissue, CEA and NCA 50 appear to be released via vesicles formed from the microvillous membrane of mature columnar cells. These results are consistent with the hypothesis that CEA and NCA play a role in the nonspecific defense against microorganisms in the large intestine.
Similar articles
-
Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.Lab Invest. 1997 May;76(5):703-16. Lab Invest. 1997. PMID: 9166289
-
Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.Cancer Res. 1991 Oct 15;51(20):5694-703. Cancer Res. 1991. PMID: 1913687
-
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.Cancer Res. 1984 Jan;44(1):285-92. Cancer Res. 1984. PMID: 6197163
-
[Carcinoembryonic antigen gene family and its clinical application].Gan To Kagaku Ryoho. 1990 Jul;17(7):1274-80. Gan To Kagaku Ryoho. 1990. PMID: 2195999 Review. Japanese.
-
[The carcinoembryonic antigen: apropos of an old friend].Rev Invest Clin. 2005 Nov-Dec;57(6):814-9. Rev Invest Clin. 2005. PMID: 16708907 Review. Spanish.
Cited by
-
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.Oncotarget. 2016 May 17;7(20):29287-305. doi: 10.18632/oncotarget.8678. Oncotarget. 2016. PMID: 27086912 Free PMC article.
-
Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells.BMC Res Notes. 2013 Sep 26;6:381. doi: 10.1186/1756-0500-6-381. BMC Res Notes. 2013. PMID: 24070190 Free PMC article.
-
Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.PLoS One. 2014 Jun 9;9(6):e98927. doi: 10.1371/journal.pone.0098927. eCollection 2014. PLoS One. 2014. PMID: 24911657 Free PMC article.
-
Carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1), apically expressed on human colonic M cells, are potential receptors for microbial adhesion.Histochem Cell Biol. 2004 Feb;121(2):83-9. doi: 10.1007/s00418-003-0613-5. Epub 2004 Jan 31. Histochem Cell Biol. 2004. PMID: 14758482
-
Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.BMC Cancer. 2005 Apr 12;5:38. doi: 10.1186/1471-2407-5-38. BMC Cancer. 2005. PMID: 15826304 Free PMC article.